GLP-1 weight loss, injectable + oral. We scored MEDVi on clinical oversight, pharmacy
sourcing, pricing transparency, catalog, and patient experience — the same five axes
we apply to every provider, before any commercial relationship.
7.2
Verification score /10
4.4 / 5
Trustpilot
2023
Founded
✓
LegitScript
Start with MEDVi
Complete the online intake — 49 states. HSA/FSA accepted.
Affiliate disclosure: Veritide earns a commission when readers start care through some provider links on this page, at no extra cost to you. Commissions never influence our scores or rankings — we do not sell placement. See our full disclosure and scoring methodology.
One of the lowest entry prices in the compounded GLP-1 category ($179 first month) and the only major provider offering both injectable AND oral formats for both semaglutide and tirzepatide. The February 2026 FDA warning letter was a marketing-claims issue, not a product-quality finding — but it's a real flag worth knowing. Refill pricing steps up sharply after month one.
Verification score
7.2
/ 10.0
GRADE C
Veritide Verification Score
MEDVi
Reviewed & verified July 2026
Clinical oversight7.0
Pharmacy sourcing7.5
Pricing transparency7.0
Catalog & availability7.0
Patient experience7.5
Weights: clinical oversight 25%, pharmacy
sourcing 25%, pricing transparency 20%, catalog 15%, patient experience 15%. See our
full methodology.
Pricing
Cash-pay only; no insurance billing. Prices below verified July 2026 —
confirm current pricing at checkout before committing.
Plan
Price
Notes
Compounded semaglutide (inj)
$179 first month, $299/mo after
Lowest entry in class
Compounded semaglutide (oral)
$249 first month, $369/mo after
Needle-free
Compounded tirzepatide
$279–$349 start, $399+/mo after
Both formats
Brand Wegovy / Zepbound
$1,999/mo + $99 membership
FDA-approved path
Pricing note
Compounded medications are not FDA-approved as finished products. Multi-month plans are often
billed upfront — read the cancellation and refund terms before selecting a longer plan.
Brand-name path available for FDA-approved preference
Watch-outs
Feb 2026 FDA warning letter (marketing claims, not product)
Refill price jumps to $299/mo after the $179 first month
Oral tablet absorption is pharmacologically weaker than injection
Billing-transparency and support complaints in reviews
Who MEDVi is best for
Best fit
Cost-sensitive GLP-1 shoppers who want the lowest first-month entry and the option of oral tablets, and who will read the refill pricing before committing.
Ready to start with MEDVi?
See if you qualify — the intake takes a few minutes and there's no charge until a clinician approves you.
Yes. MEDVi is a LegitScript-certified telehealth platform that connects patients with licensed US clinicians and FDA-registered compounding pharmacies. Compounded medications are legal but are not FDA-approved as finished products — a distinction that applies to every compounded GLP-1 provider, not just MEDVi.
How much does MEDVi cost?
Entry pricing starts at the rates in the table above; verify current pricing at checkout as it changes. MEDVi is cash-pay only and does not bill insurance, though HSA/FSA funds are generally accepted.
What pharmacy does MEDVi use?
FDA-registered 503A compounding pharmacies (Belmar Pharma Solutions named); OpenLoop provider network. Always verify the pharmacy name, active ingredient, concentration, and beyond-use date on your label when your medication arrives.
Does MEDVi require lab work?
Not required to start; doctor consult available at no extra fee. If you have diabetes, an elevated A1c, or cardiovascular risk factors, consider arranging periodic metabolic labs even when they aren't required.
What states does MEDVi serve?
49 states (not Mississippi). Availability depends on state-specific telehealth prescribing rules, so confirm your state is covered before starting intake.
Prefer the research route?
Some readers weigh prescribed therapy against research-grade peptides. We break down the real
differences in Research vs Prescribed, and you can
read the underlying science at PeptideOnline.
Affiliate disclosure: Veritide earns a commission when readers start care through some provider links on this page, at no extra cost to you. Commissions never influence our scores or rankings — we do not sell placement. See our full disclosure and scoring methodology.
Medical disclaimer: Veritide is an independent consumer-research publication, not a healthcare provider or pharmacy. This page is informational and is not medical advice. Compounded medications are not FDA-approved as finished products. Always consult a licensed clinician before starting any peptide or GLP-1 therapy.